Loading Move
Move / Case studies

Regulated medicine supply

Chemovar

Linking order records, traceability and reporting

Portfolio contributorLifon Labs
IndustryRegulated medicine supply
Project marketAustralia

Engineering contribution reported by Lifon Labs · Source review: 5 November 2026

The need

A medicine-supply platform needs to connect stock, orders and fulfilment while limiting what each audience can see. Historical stock positions also matter when preparing reports.

The approach

Lifon Labs describes contributing to role-scoped access, batch and permit records, controlled order transitions and reporting generated from completed orders.

What was delivered

  • Pharmacy-specific catalogues and quantity-based pricing.
  • Order, payment, invoice and shipment records.
  • Activity history and exports built from recorded transactions.

Result and evidence

The source describes an engineering contribution in Australia’s regulated medicine supply chain. This case study does not independently establish regulatory approval, legal compliance or permission to supply medicines.

Chemovar portfolio preview
Portfolio preview retained from MOVE’s existing work library. It is not a new live-product test.
Sources and attribution

Delivery details and scope counts are reported by Lifon Labs. They have not been independently audited by MOVE.

Work may have been completed through the contributor’s own business or earlier engagements. Inclusion does not imply a direct MOVE contract or client endorsement. Current product operation and business outcomes require separate evidence.

← Browse all 21 case studies